Quantification of HPV-16 and HPV-18 Neutralizing Antibodies via a Magnetic Bead-Based Competitive Chemiluminescence Platform.
Persistent infection with high-risk human papillomavirus (HPV) types 16 and 18 is the primary cause of cervical cancer, and vaccination is an effective prevention method. The assessment of vaccine efficacy relies on measuring neutralizing antibodies (nAbs). However, the pseudovirion-based neutralization assay (PBNA), w...